Monitor the company's ability to achieve Nasdaq compliance by the April 27, 2026 deadline and watch for signs of revenue growth from its NurseMagic platform, as the company's survival depends on successful capital raising and commercial execution in a competitive healthcare AI market.
Executive Summary
Amesite Inc. (AMST) is conducting an IPO to raise approximately $4.47 million through the offering of 2.78 million shares and accompanying warrants at an assumed price of $1.80 per share. The company, which pivoted to focus on AI-powered healthcare solutions for the post-acute care market, faces substantial risks including a history of losses, substantial doubt about its ability to continue as a going concern, and Nasdaq listing compliance issues. Proceeds will be used for working capital and general corporate purposes.
Key Financial Metrics
Key Facts
- Amesite is raising $4.47 million (up to $5.16 million if over-allotment exercised) through an IPO of 2.78 million shares and warrants at $1.80 per share
- The company has a history of significant losses: $3.6 million in 2025 and $4.4 million in 2024
- There is substantial doubt about the company's ability to continue as a going concern due to insufficient cash for the next 12 months
- The company is not in compliance with Nasdaq's $2.5 million stockholders' equity requirement and received a deficiency letter in October 2025
- Proceeds will be used for working capital and general corporate purposes with broad discretion by management
- The company pivoted from education to healthcare AI solutions, focusing on its NurseMagic platform for post-acute care
Financial Impact
Raises $4.47 million in net proceeds, increasing net tangible book value from $0.21 to $0.74 per share, but with immediate dilution of $1.06 per share to new investors
Risk Factors
- Substantial doubt about going concern status due to insufficient cash
- Risk of Nasdaq delisting for failure to meet stockholders' equity requirements
- History of significant net losses and need for substantial additional capital
- Intense competition in the healthcare software market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001213900-26-045577 |
| Document: ea028691201ex1-1.htm | 0001213900-26-045577 |
| Document: ea028691201ex4-8.htm | 0001213900-26-045577 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | DEFA14A | $0.8825 | awaiting T+60 | — | $0.5630 (−36.20%) |
Oct 14, 2026 13d ago | DEF 14A | $0.8825 | awaiting T+60 | — | $0.5630 (−36.20%) |
Jun 3, 2026 20w ago | DEFA14A | $1.39 $1.06 | ▼ −23.74% | ▼ −25.62% | $0.5630 (−59.50%) |
May 29, 2026 21w ago | EFFECT | $1.41 $1.16 | ▲ +17.73% | ▲ +18.91% | $0.5630 (+60.07%) |
May 19, 2026 23w ago | 8-K | $1.73 $1.07 | ▼ −38.15% | ▼ −44.44% | $0.5630 (−67.46%) |
May 12, 2026 24w ago | S-1 | $0.8310 $1.05 | ▼ −26.35% | ▼ −21.92% | $0.5630 (+32.25%) |
Apr 28, 2026 26w ago | 424B5 | $0.9800 $0.9519 | ▲ +2.87% | ▲ +6.86% | $0.5630 (+42.55%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▲ +6.65% | ▲ +11.42% | $0.5630 (+46.38%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▼ −6.65% | ▼ −11.42% | $0.5630 (−46.38%) |
Apr 20, 2026 27w ago | S-1 | $1.30 $1.05 | ▲ +19.23% | ▲ +26.13% | $0.5630 (+56.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers